TREA

98746778 - BEONE

Follow

Information

  • Trademark
  • 98746778
  • Serial Number
    98746778
  • Filing Date
    September 12, 2024
    a year ago
  • Transaction Date
    July 11, 2025
    4 months ago
  • Status Date
    June 10, 2025
    5 months ago
  • Published for Opposition Date
    April 15, 2025
    7 months ago
  • Location Date
    June 10, 2025
    5 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    QUEEN, ESTHER
  • Attorney Docket Number
    140679600754
    Attorney Name
    Kristen Ruisi
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BEONE
Case File Statements
  • GS0401: Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • GS0051: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • PM0001: BE ONE; BE 1
  • GS0441: Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
  • GS0421: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Case File Event Statements
  • 9/12/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/16/2024 - a year ago
    3 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 1/24/2025 - 9 months ago
    4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/12/2025 - 8 months ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/17/2025 - 7 months ago
    6 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/17/2025 - 7 months ago
    9 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/17/2025 - 7 months ago
    7 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/17/2025 - 7 months ago
    8 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/16/2024 - a year ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 3/17/2025 - 7 months ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/15/2025 - 7 months ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/9/2025 - 7 months ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/15/2025 - 7 months ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/10/2025 - 5 months ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/9/2025 - 4 months ago
    15 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 7/10/2025 - 4 months ago
    16 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN